A new trading day began on Monday, with Inovio Pharmaceuticals Inc (NASDAQ: INO) stock price up 5.00% from the previous day of trading, before settling in for the closing price of $2.00. INO’s price has ranged from $1.42 to $12.33 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -44.44% over the last five years. Meanwhile, its annual earnings per share averaged 47.65%. With a float of $36.39 million, this company’s outstanding shares have now reached $36.67 million.
The firm has a total of 134 workers. Let’s measure their productivity. In terms of profitability, gross margin is -636.81%, operating margin of -11541102.4%, and the pretax margin is -20624824.93%.
Inovio Pharmaceuticals Inc (INO) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Inovio Pharmaceuticals Inc is 0.79%, while institutional ownership is 37.18%.
Inovio Pharmaceuticals Inc (INO) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.61 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 47.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 39.23% during the next five years compared to 22.92% growth over the previous five years of trading.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Trading Performance Indicators
Here are Inovio Pharmaceuticals Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 2.63. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 275.07.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.19, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -1.79 in one year’s time.
Technical Analysis of Inovio Pharmaceuticals Inc (INO)
Analysing the last 5-days average volume posted by the [Inovio Pharmaceuticals Inc, INO], we can find that recorded value of 0.65 million was lower than the volume posted last year of 0.75 million. As of the previous 9 days, the stock’s Stochastic %D was 44.76%. Additionally, its Average True Range was 0.13.
During the past 100 days, Inovio Pharmaceuticals Inc’s (INO) raw stochastic average was set at 70.10%, which indicates a significant increase from 65.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.47% in the past 14 days, which was lower than the 72.99% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.83, while its 200-day Moving Average is $3.54. Now, the first resistance to watch is $2.17. This is followed by the second major resistance level at $2.24. The third major resistance level sits at $2.32. If the price goes on to break the first support level at $2.01, it is likely to go to the next support level at $1.93. Should the price break the second support level, the third support level stands at $1.86.
Inovio Pharmaceuticals Inc (NASDAQ: INO) Key Stats
With a market capitalization of 77.02 million, the company has a total of 36,674K Shares Outstanding. Currently, annual sales are 220 K while annual income is -107,250 K. The company’s previous quarter sales were 70 K while its latest quarter income was -19,690 K.
